What are you searching for?

21.01.2022 | Tracker

Respiratory Tracker: HCPs shared how to prevent and control seasonal respiratory infections

By Mark Sullivan

Each month, CREATION.co’s respiratory tracking update brings you the latest insights into the online UK healthcare professional (HCP) conversation regarding respiratory disease.

The conversation level of UK HCPs discussing respiratory disease on Twitter

Kicking off the first respiratory tracker of 2022, the activity of UK HCPs discussing respiratory disease online, between 21 December and 20 January, increased in volume for the first time in 3 months, to 3,484 mentions. Carrying on from 2021, the volume of COVID-19 related posts was less than the volume of non COVID-19 respiratory disease mentions for UK HCPs. However, 1,583 posts was the highest number of COVID-19 related mentions from UK HCPs since January 2021.

09 January saw the most respiratory disease online posts from UK HCPs this month. Many of these posts were encouraging people to be vaccinated against COVID-19, such as from doctor Elin Roddy who shared her opinions on the importance of vaccination and professor of palliative medicine Simon Noble, who humorously described the benefits to his colleagues of him having received vaccination. Noble’s post was the most shared respiratory disease post by UK HCPs this month with over 50 UK HCP retweets.  

The most shared story by UK HCPs this month was the ‘Infection prevention and control for seasonal respiratory infections in health and care settings (including SARS-CoV-2) for winter 2021 to 2022’ guidance, which was released on behalf of UKHSA. The guidance was met with mixed responses from HCPs, with some approving the new advice, but other UK HCPs criticising elements of the guidance, such as it not being drastic enough.

HCPs used the hashtag #covid19 126 times this month, to share the latest developments surrounding the disease, as well as their own opinion. Many HCPs also used this hashtag to draw attention to other airborne respiratory viruses such as bronchiolitis and rhinovirus, which have had less hospitalisations than usual this past year, particularly among young people. HCPs also hoped that people would continue with their passion for ameliorating the risk of airborne viruses increasing education for people to truly understand other respiratory diseases. 

Finally, UK HCPs also shared their experiences of the pressures currently facing the NHS and their colleagues. With problems such as short staffing and the need to discharge patients as quickly as possible, having a detrimental effect on the health system, this is only being exacerbated by the recent wave of Omicron and COVID-19 in general, and has been met with a cry for help towards the government.   

Each month, we track the HCP conversation relating to respiratory disease.

You can keep up to date with this and other pharmaceutical tracking updates, including COVID-19 developments, within the Tracking section of CREATION Knowledge, or sign up to receive our monthly eJournal with all of our latest HCP insights. 

If you would like to dig deeper into what we have seen this month then please do get in touch.

Methodology

  • This article analysed the Twitter conversations of HCPs in the UK discussing respiratory disease and related terms between 21 December 2021 and 20 January 2022 using CREATION Pinpoint®.
  • Between 21 December 2021 and 20 January 2022, there were 3,484 UK HCP mentions of respiratory disease and related terms, from 1,583 unique UK HCP authors. 

View the latest respiratory tracker and archived trackers

View all articles >

Meet the Author

Mark Sullivan

Mark uses his passion for data analysis to study the online conversations of HCPs and find actionable insights which are presented to teams in the pharmaceutical industry so they can make informed decisions.

Mark is an avid sports fan whether watching or playing. He enjoys spending time with his family and friends – but not as much when they tell him he needs a haircut.

Suggested next


02.03.2021 | Article

Top 50 Pharma Tracker: J&J FDA approval of single-dose vaccine stirs HCP conversations

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Maria Aguirre

27.07.2021 | Whitepaper

White Paper: Digital Opinion Leaders are more important than ever

Around a decade ago, we saw the emergence of a new behaviour: healthcare professionals were

View all articles >